EHS
EHS

Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations




TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations

Source link

EHS
Back to top button